HSP90 inhibitor STA‐9090 potently suppresses secondary KIT kinase‐domain mutations responsible for gastrointestinal stromal tumor (GIST) progression during imatinib therapy
Proceedings article published in 2010 by
JA; Debiec-Rychter Maria; U0002394; Swank S; Morgan J; Liegl B; Rege Ta; Heinrich Mc; Corless Cl; Donsky R; Fletcher Cdm; Raut Cp; Marino-Enriquez A; Blackman Rk; Proja D; Sang J; Smith D; Foley Kp; Ou W; Wang Y; Demetri Gd; Jla Fletcher
Abstract
status: published